In the SURPASS-2 trial, patients with obesity and T2D who received tirzeapatide (5 mg weekly) achieved greater HbA1c and body weight reductions than those receiving semaglutide (1 mg weekly) during the 40 week study (64) despite comparable putative GLP-1R occupancy at these doses (47)
Keep reading Published on: September 17, 2025 JohnElliottCare John Elliott was a builder who enjoyed meeting with clients and planning their future homes
This might involve collaboration between your GP, practice nurse, diabetes specialist, and mental health services to optimise your overall wellbeing
Some medications may benefit from reaching room temperature before injection to reduce discomfort, but this varies by productcheck your medication's Instructions for Use (IFU)
These medications are highly effective, often leading to significant health improvements with minimal side effects
The FDA is reconsidering its decision to remove Eli Lillys drugs, Zepbound and Mounjaro, from the shortage list, temporarily allowing compounding facilities to continue producing alternative versions